Maximizing the Benefits of Local Literature Screening in Pharmacovigilance
Pharmacovigilance, the process of monitoring drug safety, is a crucial aspect of ensuring the well-being of patients. A critical element of pharmacovigilance is local literature screening, which involves actively searching for and reviewing information from local sources to identify potential adverse drug reactions (ADRs) and other safety concerns. By monitoring local literature, pharmacovigilance professionals can better understand the drug safety profile in a specific population or region.
Advantages of local medical literature screening
The benefits of local literature screening in pharmacovigilance are numerous. One significant advantage is that it identifies ADRs that may not have been reported through traditional channels, such as clinical trials or spontaneous reporting systems. This can help to identify previously unknown safety concerns and improve the overall drug safety profile. In addition, local literature screening can help to identify demographic factors that may impact drug safety. For example, certain populations may have different ADR rates due to genetic or lifestyle factors. By monitoring local literature, pharmacovigilance professionals can better understand these factors and develop strategies to mitigate potential risks. Furthermore, local literature screening can help improve pharmacovigilance activities’ overall effectiveness. By identifying ADRs and other safety concerns early on, local literature screening can help to prevent serious adverse events and protect the public from harm.
Challenges of local medical literature screening
However, there are also some challenges associated with local literature screening. One major challenge is that it can be time-consuming and resource-intensive, as it requires a significant amount of manual searching and reviewing. Additionally, there may be language barriers or other cultural factors that make it difficult to access and interpret local literature.
The DrugCard platform will help you cope with all challenges!
This is where our software – DrugCard comes in. DrugCard is a cost-effective, full-regulatory compliant software designed specifically for drug safety departments to automate medical literature screening. With DrugCard, medical literature can be scanned automatically 60 times faster than any human can, reducing the risk of errors. Our proprietary technology is able to recognize even poorly scanned journals with 99% accuracy. Using DrugCard is as easy as 1-2-3. Simply add the medicines you want to track to our system, and if DrugCard finds any mention of the company’s medicines, the drug safety specialist will receive a notification by e-mail.
Improve the literature monitoring process together with the DrugCard platform
In conclusion, local literature screening is an important aspect of pharmacovigilance that can help to identify ADRs and other safety concerns that may not have been reported through traditional channels. Screening the literature for mentions of medicinal products turns out to be a colossal task. Of course, automating the search process decreases the manual effort and time spent on monitoring. By using a software like DrugCard, pharmacovigilance professionals can automate the process and maximize the benefits of local literature screening, ensuring the safety and well-being of patients and the public. DrugCard makes the process of literature screening less time-consuming, error-prone and more efficient. Don’t forget to try it in practice with free trial access to the DrugCard platform.